You are using an outdated browser. Please upgrade your browser to improve your experience.
NLA ASCVD Risk Assessment Tool

The National Lipid Association Risk Assessment Tool is based on the NLA’s 2014 Publication: NLA Recommendations for the Patient-Centered Management of Dyslipidemia Part 1

The National Lipid Association Risk Assessment Tool is based on the NLA’s 2014 Publication: NLA Recommendations for the Patient-Centered Management of Dyslipidemia Part 1

NLA ASCVD Risk Assessment Tool

by The National Lipid Association
NLA ASCVD Risk Assessment Tool
NLA ASCVD Risk Assessment Tool

What is it about?

The National Lipid Association Risk Assessment Tool is based on the NLA’s 2014 Publication: NLA Recommendations for the Patient-Centered Management of Dyslipidemia Part 1. The National Lipid Association released its recommendations, published in the Journal of Clinical Lipidology on September 15, 2014. In the recommendations, the Expert Panel re-affirms the importance of cholesterol goals for the prevention of heart attack and stroke. The recommendations should serve as guidance to clinicians for treating patients with dyslipidemia.

NLA ASCVD Risk Assessment Tool

App Details

Version
1.0.1
Rating
NA
Size
0Mb
Genre
Medical Health & Fitness
Last updated
July 9, 2015
Release date
May 27, 2015
More info

App Store Description

The National Lipid Association Risk Assessment Tool is based on the NLA’s 2014 Publication: NLA Recommendations for the Patient-Centered Management of Dyslipidemia Part 1. The National Lipid Association released its recommendations, published in the Journal of Clinical Lipidology on September 15, 2014. In the recommendations, the Expert Panel re-affirms the importance of cholesterol goals for the prevention of heart attack and stroke. The recommendations should serve as guidance to clinicians for treating patients with dyslipidemia.

Building on the work of traditional risk calculators, this unique tool offers a step-by-step risk factor elimination process that exposes all the variables used in determining patient risk for Atherosclerotic Cardiovascular Disease. The NLA ASCVD Risk Assessment Tool provides clear, evidence-based support for risk classification, setting appropriate treatment targets and making therapeutic guidance.

While this tool can be downloaded by anyone, this instrument is designed for use by physicians and allied healthcare professionals. This application should be used to supplement, but not replace, the provider’s clinical judgment. Therapeutic options should be individualized and determined between provider and patient. The NLA does not assume any responsibility for any aspect of healthcare administered or not administered with the aid of the information provided within this application.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to [email protected] and your information will be removed.